Summary
The TAP2 gene, located in the HLA class II region, encodes a subunit of a transporter involved in the endogenous antigen-processing pathway, and has been suggested to contribute to the genetic risk for insulin-dependent diabetes (IDDM). In order to determine whether the TAP2 locus modulates the risk conferred by HLA DQ loci, HLA DQA1-DQB1-TAP2 haplotypes were analysed in 48 IDDM probands, their first degree relatives, and in 62 normal control subjects. A decreased frequency of the TAP2B allele was confirmed in this IDDM cohort (12 vs 28% in control subjects, p c <0.05). Analysis of 73 informative meiotic events in IDDM and control families demonstrated a recombination fraction between HLA DQB1 and TAP2 loci of 0.041 (Log of the odds score=16.5; p<10−8) indicating strong linkage between these loci. Family haplotype analysis demonstrated linkage disequilibrium between TAP2 and HLA DQA1-DQB1, and showed that the reduced frequency of TAP2B was associated with its absence on the IDDM susceptible DQA1*0301-DQB1*0302 haplotype, its low frequency on DQA1*0501-DQB1*0201, and the association of TAP2B with DQA1*0101-DQB1*0501 haplotypes which were less frequent in IDDM patients. Comparison of transmitted with non-transmitted haplotypes in IDDM families showed a slight but not significant decrease in TAP2B allele frequency on transmitted (3 of 37) vs non-transmitted (2 of 9) HLA DQA1*0501-DQB1*0201 haplotypes. No other differences were observed. Twenty-four unrelated DQA1*0501-DQB1*0201 haplotypes from non-diabetic families had a TAP2B allele frequency (4%) similar to that in IDDM haplotypes. These findings suggest that the decreased TAP2B allele frequency in Italian IDDM patients is due to HLA DQ haplotype differences between IDDM patients and control subjects, and do not support a contribution to IDDM risk by the TAP2 locus.
Article PDF
Similar content being viewed by others
Abbreviations
- ARMS:
-
Amplificatory refractory mutation system
- IDDM:
-
insulin-dependent diabetes mellitus
- MHC:
-
major histocompatibility complex
- PCR:
-
polymerase chain reaction
- TAP:
-
transporter associated with antigen processing
References
Tiwari Jl, Terasaki PI (1985) HLA and disease associations. Springer, New York
Nepom GT, Erlich H (1991) MHC class II molecules and autoimmunity. Ann Rev Immunol 90: 493–525
Sterkers G, Zeliszewski D, Chausée AM et al. (1988) HLA-DQ rather than HLA-DR region might be involved in dominant non susceptibility to diabetes. Proc Natl Acad Sci USA 85: 6473–6477
Todd JA, Bell JI, McDevitt HO (1987) HLA-DQΒ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604
Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M (1988) Aspartic acid at position 57 of the HLA-DQΒ chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 85: 8111–8115
Dorman JS, LaPorte RE, Stone RA, Trucco M (1990) World-wide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQΒ chain. Proc Natl Acad Sci USA 87: 7370–7374
Khalil H, d'Auriol L, Gobet M et al. (1990) A combination of HLA-DQΒ Asp 57-negative and HLA-DQα Arg 52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85: 1315–1319
Baish JM, Weeks T, Giles R, Hoover M, Stastny P, Capra D (1990) Analysis of HLA DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322: 1836–1846
RØnningen KS, Spurkland A, Tait BD et al. (1993) Joint report: HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese, 11th International Histocompatibility Workshop. In: Tsuji et al. (eds) HLA 1991. Proceedings of the 11th International Histocompatibility Workshop and Conference, vol 1. Oxford University Press, Oxford, pp 713–722
Kaufman JF, Auffray C, Korman AJ, Shackelford DA, Strominger JL (1984) The class II molecules of human and murine major histocompatibility complex. Cell 36: 1–13
Todd JH, Acha-Orbea H, Bell JI et al. (1988) A molecular basis for MHC class II-associated autoimmunity. Science 240: 1003–1009
Campbell RD, Trowsdale J (1993) Map of the human major histocompatibility complex. Immunol Today 14: 349–352
Deverson EV, Gow IR, Coadwell J, Monaco JJ, Butcher GW, Howard JC (1990) MHC class II region encoding proteins related to the multidrug resistance family of trans-membrane transporters. Nature 348: 738–741
Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A (1990) Sequences encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters. Nature 348: 741–744
Spies T, Bresnahan M, Bahram S et al. (1990) A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744–747
Morris P, Shaman J, Attaya M et al.(1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368: 551–554
Fling SP, Arp B, Pious D (1994) HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368: 554–558
Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287–299
Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R (1992) Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355: 644–646
Neefjes JJ, Momburg F, HÄmmerling GJ (1993) Selective and ATP dependent translocation of peptides by the MHC-encoded transporter. Science 261: 769–771
Townsend A, öhlén C, Bastin J, Ljunggren HG, Foster L, KÄrre K (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340: 443–448
Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J (1992) Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357: 342–344
Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J (1993) Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37: 373–380
Colonna M, Bresnahan M, Bahram S, Strominger JL (1992) Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 89: 3932–3936
RØnningen KS, Undlien DE, Ploski R et al. (1993) Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus. Eur J Immunol 23: 1050–1056
Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach JF (1993) Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 23: 1784–1788
Maniatis TM, Fritsch EF, Sambrook J (1982) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, New York
Thomson G (1988) HLA disease associations: models for insulin dependent diabetes mellitus and the study of complex human genetic disorders. Annu Rev Genet 22: 31–50
Ott J (1991) Analysis of human genetic linkage. The Johns Hopkins University Press, Baltimore London
Arnheim N, Strange C, Herlich H (1985) Used of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci USA 82: 6970–6974
McGinnis RE, Spielman RS (1994) Linkage disequilibrium in the insulin gene region: size variation at the 5′ flanking polymorphism and bimodality among “class I” alleles. Am J Hum Genet 55: 526–532
Martinez-Laso J, Martin-Villa JM, Alvarez M, Martinez-Quiles N, Lledo G, Arnaiz-Villena A (1994) Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens 44: 184–188
Cucca F, Congia M, Trowsdale J, Powis SH (1994) Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 44: 234–240
Green A, Gale EAM, Patterson CC (1992) Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 339: 905–909
Jackson DJ, Capra JD (1993) TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility. Proc Natl Acad Sci USA 90: 11079–11083
Ott J (1989) Statistical properties of the haplotype relative risk. Genet Epidemiol 6: 127–130
Petrovsky N, Harrison LC (1995) HLA-matched control subjects are essential in studies of susceptibility to IDDM. Diabetologia 38: 125–126 (Letter)
Degli-Esposti MA, Andreas A, Christiansen FT, Schalke B, Albert E, Dawkins RL (1992) An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 35: 355–364
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Esposito, L., Lampasona, V., Bosi, E. et al. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia 38, 968–974 (1995). https://doi.org/10.1007/BF00400587
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400587